0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 3-Aminobenzylamine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-36A17027
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global 3 Aminobenzylamine Market Research Report 2024
BUY CHAPTERS

Global 3-Aminobenzylamine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-36A17027
Report
November 2025
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

3-Aminobenzylamine Market

The global 3-Aminobenzylamine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Dye Intermediates accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
3-Aminobenzylamine leading manufacturers including Trans World Chemicals, Inc., Anisyn, Inc., Mitsui Chemicals, Inc., Robinson Brothers Limited, Synbias Ltd., Spectrochem Private Limited, Indo Amines Limited, Sinochem, Hunan Huateng Pharmaceutical, Hebei Mojin Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Trans World Chemicals, Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global 3-Aminobenzylamine market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of 3-Aminobenzylamine Market Report

Report Metric Details
Report Name 3-Aminobenzylamine Market
Segment by Type
  • Purity 99%
  • Purity 98%
  • Purity 97%
Segment by Application
  • Dye Intermediates
  • Pharmaceutical Intermediates
  • Resin Curing Agent
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
  • India
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Trans World Chemicals, Inc., Anisyn, Inc., Mitsui Chemicals, Inc., Robinson Brothers Limited, Synbias Ltd., Spectrochem Private Limited, Indo Amines Limited, Sinochem, Hunan Huateng Pharmaceutical, Hebei Mojin Biotechnology, Suzhou Jingye Medicine & Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the 3-Aminobenzylamine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the 3-Aminobenzylamine Market report?

Ans: The main players in the 3-Aminobenzylamine Market are Trans World Chemicals, Inc., Anisyn, Inc., Mitsui Chemicals, Inc., Robinson Brothers Limited, Synbias Ltd., Spectrochem Private Limited, Indo Amines Limited, Sinochem, Hunan Huateng Pharmaceutical, Hebei Mojin Biotechnology, Suzhou Jingye Medicine & Chemical

What are the Application segmentation covered in the 3-Aminobenzylamine Market report?

Ans: The Applications covered in the 3-Aminobenzylamine Market report are Dye Intermediates, Pharmaceutical Intermediates, Resin Curing Agent, Other

What are the Type segmentation covered in the 3-Aminobenzylamine Market report?

Ans: The Types covered in the 3-Aminobenzylamine Market report are Purity 99%, Purity 98%, Purity 97%

1 Study Coverage
1.1 Introduction to 3-Aminobenzylamine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global 3-Aminobenzylamine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 99%
1.2.3 Purity 98%
1.2.4 Purity 97%
1.3 Market Segmentation by Application
1.3.1 Global 3-Aminobenzylamine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dye Intermediates
1.3.3 Pharmaceutical Intermediates
1.3.4 Resin Curing Agent
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global 3-Aminobenzylamine Revenue Estimates and Forecasts 2020-2031
2.2 Global 3-Aminobenzylamine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global 3-Aminobenzylamine Sales Estimates and Forecasts 2020-2031
2.4 Global 3-Aminobenzylamine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global 3-Aminobenzylamine Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
3.4.5 India
4 Competition by Manufacturers
4.1 Global 3-Aminobenzylamine Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global 3-Aminobenzylamine Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 99% Market Size by Manufacturers
4.5.2 Purity 98% Market Size by Manufacturers
4.5.3 Purity 97% Market Size by Manufacturers
4.6 Global 3-Aminobenzylamine Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global 3-Aminobenzylamine Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global 3-Aminobenzylamine Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global 3-Aminobenzylamine Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global 3-Aminobenzylamine Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America 3-Aminobenzylamine Sales and Revenue by Type (2020-2031)
7.4 North America 3-Aminobenzylamine Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America 3-Aminobenzylamine Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe 3-Aminobenzylamine Sales and Revenue by Type (2020-2031)
8.4 Europe 3-Aminobenzylamine Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe 3-Aminobenzylamine Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific 3-Aminobenzylamine Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific 3-Aminobenzylamine Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific 3-Aminobenzylamine Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America 3-Aminobenzylamine Sales and Revenue by Type (2020-2031)
10.4 Central and South America 3-Aminobenzylamine Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America 3-Aminobenzylamine Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa 3-Aminobenzylamine Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa 3-Aminobenzylamine Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa 3-Aminobenzylamine Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Trans World Chemicals, Inc.
12.1.1 Trans World Chemicals, Inc. Corporation Information
12.1.2 Trans World Chemicals, Inc. Business Overview
12.1.3 Trans World Chemicals, Inc. 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.1.4 Trans World Chemicals, Inc. 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Trans World Chemicals, Inc. 3-Aminobenzylamine Sales by Product in 2024
12.1.6 Trans World Chemicals, Inc. 3-Aminobenzylamine Sales by Application in 2024
12.1.7 Trans World Chemicals, Inc. 3-Aminobenzylamine Sales by Geographic Area in 2024
12.1.8 Trans World Chemicals, Inc. 3-Aminobenzylamine SWOT Analysis
12.1.9 Trans World Chemicals, Inc. Recent Developments
12.2 Anisyn, Inc.
12.2.1 Anisyn, Inc. Corporation Information
12.2.2 Anisyn, Inc. Business Overview
12.2.3 Anisyn, Inc. 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.2.4 Anisyn, Inc. 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Anisyn, Inc. 3-Aminobenzylamine Sales by Product in 2024
12.2.6 Anisyn, Inc. 3-Aminobenzylamine Sales by Application in 2024
12.2.7 Anisyn, Inc. 3-Aminobenzylamine Sales by Geographic Area in 2024
12.2.8 Anisyn, Inc. 3-Aminobenzylamine SWOT Analysis
12.2.9 Anisyn, Inc. Recent Developments
12.3 Mitsui Chemicals, Inc.
12.3.1 Mitsui Chemicals, Inc. Corporation Information
12.3.2 Mitsui Chemicals, Inc. Business Overview
12.3.3 Mitsui Chemicals, Inc. 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.3.4 Mitsui Chemicals, Inc. 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Mitsui Chemicals, Inc. 3-Aminobenzylamine Sales by Product in 2024
12.3.6 Mitsui Chemicals, Inc. 3-Aminobenzylamine Sales by Application in 2024
12.3.7 Mitsui Chemicals, Inc. 3-Aminobenzylamine Sales by Geographic Area in 2024
12.3.8 Mitsui Chemicals, Inc. 3-Aminobenzylamine SWOT Analysis
12.3.9 Mitsui Chemicals, Inc. Recent Developments
12.4 Robinson Brothers Limited
12.4.1 Robinson Brothers Limited Corporation Information
12.4.2 Robinson Brothers Limited Business Overview
12.4.3 Robinson Brothers Limited 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.4.4 Robinson Brothers Limited 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Robinson Brothers Limited 3-Aminobenzylamine Sales by Product in 2024
12.4.6 Robinson Brothers Limited 3-Aminobenzylamine Sales by Application in 2024
12.4.7 Robinson Brothers Limited 3-Aminobenzylamine Sales by Geographic Area in 2024
12.4.8 Robinson Brothers Limited 3-Aminobenzylamine SWOT Analysis
12.4.9 Robinson Brothers Limited Recent Developments
12.5 Synbias Ltd.
12.5.1 Synbias Ltd. Corporation Information
12.5.2 Synbias Ltd. Business Overview
12.5.3 Synbias Ltd. 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.5.4 Synbias Ltd. 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Synbias Ltd. 3-Aminobenzylamine Sales by Product in 2024
12.5.6 Synbias Ltd. 3-Aminobenzylamine Sales by Application in 2024
12.5.7 Synbias Ltd. 3-Aminobenzylamine Sales by Geographic Area in 2024
12.5.8 Synbias Ltd. 3-Aminobenzylamine SWOT Analysis
12.5.9 Synbias Ltd. Recent Developments
12.6 Spectrochem Private Limited
12.6.1 Spectrochem Private Limited Corporation Information
12.6.2 Spectrochem Private Limited Business Overview
12.6.3 Spectrochem Private Limited 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.6.4 Spectrochem Private Limited 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Spectrochem Private Limited Recent Developments
12.7 Indo Amines Limited
12.7.1 Indo Amines Limited Corporation Information
12.7.2 Indo Amines Limited Business Overview
12.7.3 Indo Amines Limited 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.7.4 Indo Amines Limited 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Indo Amines Limited Recent Developments
12.8 Sinochem
12.8.1 Sinochem Corporation Information
12.8.2 Sinochem Business Overview
12.8.3 Sinochem 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.8.4 Sinochem 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Sinochem Recent Developments
12.9 Hunan Huateng Pharmaceutical
12.9.1 Hunan Huateng Pharmaceutical Corporation Information
12.9.2 Hunan Huateng Pharmaceutical Business Overview
12.9.3 Hunan Huateng Pharmaceutical 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.9.4 Hunan Huateng Pharmaceutical 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Hunan Huateng Pharmaceutical Recent Developments
12.10 Hebei Mojin Biotechnology
12.10.1 Hebei Mojin Biotechnology Corporation Information
12.10.2 Hebei Mojin Biotechnology Business Overview
12.10.3 Hebei Mojin Biotechnology 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.10.4 Hebei Mojin Biotechnology 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Hebei Mojin Biotechnology Recent Developments
12.11 Suzhou Jingye Medicine & Chemical
12.11.1 Suzhou Jingye Medicine & Chemical Corporation Information
12.11.2 Suzhou Jingye Medicine & Chemical Business Overview
12.11.3 Suzhou Jingye Medicine & Chemical 3-Aminobenzylamine Product Models, Descriptions and Specifications
12.11.4 Suzhou Jingye Medicine & Chemical 3-Aminobenzylamine Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Suzhou Jingye Medicine & Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 3-Aminobenzylamine Industry Chain
13.2 3-Aminobenzylamine Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 3-Aminobenzylamine Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 3-Aminobenzylamine Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 3-Aminobenzylamine Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global 3-Aminobenzylamine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global 3-Aminobenzylamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global 3-Aminobenzylamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global 3-Aminobenzylamine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global 3-Aminobenzylamine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global 3-Aminobenzylamine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global 3-Aminobenzylamine Sales by Region (2020-2025) & (Tons)
 Table 8. Global 3-Aminobenzylamine Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global 3-Aminobenzylamine Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global 3-Aminobenzylamine Production by Region (2020-2025) & (Tons)
 Table 12. Global 3-Aminobenzylamine Production by Region (2026-2031) & (Tons)
 Table 13. Global 3-Aminobenzylamine Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global 3-Aminobenzylamine Sales Share by Manufacturers (2020-2025)
 Table 15. Global 3-Aminobenzylamine Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global 3-Aminobenzylamine Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global 3-Aminobenzylamine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3-Aminobenzylamine as of 2024)
 Table 19. Global 3-Aminobenzylamine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global 3-Aminobenzylamine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers 3-Aminobenzylamine Manufacturing Base and Headquarters
 Table 22. Global 3-Aminobenzylamine Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global 3-Aminobenzylamine Sales by Type (2020-2025) & (Tons)
 Table 26. Global 3-Aminobenzylamine Sales by Type (2026-2031) & (Tons)
 Table 27. Global 3-Aminobenzylamine Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global 3-Aminobenzylamine Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global 3-Aminobenzylamine ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global 3-Aminobenzylamine Sales by Application (2020-2025) & (Tons)
 Table 32. Global 3-Aminobenzylamine Sales by Application (2026-2031) & (Tons)
 Table 33. 3-Aminobenzylamine High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global 3-Aminobenzylamine Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global 3-Aminobenzylamine Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global 3-Aminobenzylamine ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America 3-Aminobenzylamine Growth Accelerators and Market Barriers
 Table 40. North America 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America 3-Aminobenzylamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe 3-Aminobenzylamine Growth Accelerators and Market Barriers
 Table 43. Europe 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe 3-Aminobenzylamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific 3-Aminobenzylamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific 3-Aminobenzylamine Growth Accelerators and Market Barriers
 Table 48. Southeast Asia 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America 3-Aminobenzylamine Investment Opportunities and Key Challenges
 Table 50. Central and South America 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa 3-Aminobenzylamine Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa 3-Aminobenzylamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Trans World Chemicals, Inc. Corporation Information
 Table 54. Trans World Chemicals, Inc. Description and Major Businesses
 Table 55. Trans World Chemicals, Inc. Product Models, Descriptions and Specifications
 Table 56. Trans World Chemicals, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Trans World Chemicals, Inc. Sales Value Proportion by Product in 2024
 Table 58. Trans World Chemicals, Inc. Sales Value Proportion by Application in 2024
 Table 59. Trans World Chemicals, Inc. Sales Value Proportion by Geographic Area in 2024
 Table 60. Trans World Chemicals, Inc. 3-Aminobenzylamine SWOT Analysis
 Table 61. Trans World Chemicals, Inc. Recent Developments
 Table 62. Anisyn, Inc. Corporation Information
 Table 63. Anisyn, Inc. Description and Major Businesses
 Table 64. Anisyn, Inc. Product Models, Descriptions and Specifications
 Table 65. Anisyn, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Anisyn, Inc. Sales Value Proportion by Product in 2024
 Table 67. Anisyn, Inc. Sales Value Proportion by Application in 2024
 Table 68. Anisyn, Inc. Sales Value Proportion by Geographic Area in 2024
 Table 69. Anisyn, Inc. 3-Aminobenzylamine SWOT Analysis
 Table 70. Anisyn, Inc. Recent Developments
 Table 71. Mitsui Chemicals, Inc. Corporation Information
 Table 72. Mitsui Chemicals, Inc. Description and Major Businesses
 Table 73. Mitsui Chemicals, Inc. Product Models, Descriptions and Specifications
 Table 74. Mitsui Chemicals, Inc. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Mitsui Chemicals, Inc. Sales Value Proportion by Product in 2024
 Table 76. Mitsui Chemicals, Inc. Sales Value Proportion by Application in 2024
 Table 77. Mitsui Chemicals, Inc. Sales Value Proportion by Geographic Area in 2024
 Table 78. Mitsui Chemicals, Inc. 3-Aminobenzylamine SWOT Analysis
 Table 79. Mitsui Chemicals, Inc. Recent Developments
 Table 80. Robinson Brothers Limited Corporation Information
 Table 81. Robinson Brothers Limited Description and Major Businesses
 Table 82. Robinson Brothers Limited Product Models, Descriptions and Specifications
 Table 83. Robinson Brothers Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Robinson Brothers Limited Sales Value Proportion by Product in 2024
 Table 85. Robinson Brothers Limited Sales Value Proportion by Application in 2024
 Table 86. Robinson Brothers Limited Sales Value Proportion by Geographic Area in 2024
 Table 87. Robinson Brothers Limited 3-Aminobenzylamine SWOT Analysis
 Table 88. Robinson Brothers Limited Recent Developments
 Table 89. Synbias Ltd. Corporation Information
 Table 90. Synbias Ltd. Description and Major Businesses
 Table 91. Synbias Ltd. Product Models, Descriptions and Specifications
 Table 92. Synbias Ltd. Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Synbias Ltd. Sales Value Proportion by Product in 2024
 Table 94. Synbias Ltd. Sales Value Proportion by Application in 2024
 Table 95. Synbias Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 96. Synbias Ltd. 3-Aminobenzylamine SWOT Analysis
 Table 97. Synbias Ltd. Recent Developments
 Table 98. Spectrochem Private Limited Corporation Information
 Table 99. Spectrochem Private Limited Description and Major Businesses
 Table 100. Spectrochem Private Limited Product Models, Descriptions and Specifications
 Table 101. Spectrochem Private Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Spectrochem Private Limited Recent Developments
 Table 103. Indo Amines Limited Corporation Information
 Table 104. Indo Amines Limited Description and Major Businesses
 Table 105. Indo Amines Limited Product Models, Descriptions and Specifications
 Table 106. Indo Amines Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Indo Amines Limited Recent Developments
 Table 108. Sinochem Corporation Information
 Table 109. Sinochem Description and Major Businesses
 Table 110. Sinochem Product Models, Descriptions and Specifications
 Table 111. Sinochem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Sinochem Recent Developments
 Table 113. Hunan Huateng Pharmaceutical Corporation Information
 Table 114. Hunan Huateng Pharmaceutical Description and Major Businesses
 Table 115. Hunan Huateng Pharmaceutical Product Models, Descriptions and Specifications
 Table 116. Hunan Huateng Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Hunan Huateng Pharmaceutical Recent Developments
 Table 118. Hebei Mojin Biotechnology Corporation Information
 Table 119. Hebei Mojin Biotechnology Description and Major Businesses
 Table 120. Hebei Mojin Biotechnology Product Models, Descriptions and Specifications
 Table 121. Hebei Mojin Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. Hebei Mojin Biotechnology Recent Developments
 Table 123. Suzhou Jingye Medicine & Chemical Corporation Information
 Table 124. Suzhou Jingye Medicine & Chemical Description and Major Businesses
 Table 125. Suzhou Jingye Medicine & Chemical Product Models, Descriptions and Specifications
 Table 126. Suzhou Jingye Medicine & Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Suzhou Jingye Medicine & Chemical Recent Developments
 Table 128. Key Raw Materials Distribution
 Table 129. Raw Materials Key Suppliers
 Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 131. Milestones in Production Technology Evolution
 Table 132. Distributors List
 Table 133. Market Trends and Market Evolution
 Table 134. Market Drivers and Opportunities
 Table 135. Market Challenges, Risks, and Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. 3-Aminobenzylamine Product Picture
 Figure 2. Global 3-Aminobenzylamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Purity 99% Product Picture
 Figure 4. Purity 98% Product Picture
 Figure 5. Purity 97% Product Picture
 Figure 6. Global 3-Aminobenzylamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Dye Intermediates
 Figure 8. Pharmaceutical Intermediates
 Figure 9. Resin Curing Agent
 Figure 10. Other
 Figure 11. 3-Aminobenzylamine Report Years Considered
 Figure 12. Global 3-Aminobenzylamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 14. Global 3-Aminobenzylamine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global 3-Aminobenzylamine Revenue Market Share by Region (2020-2031)
 Figure 16. Global 3-Aminobenzylamine Sales (2020-2031) & (Tons)
 Figure 17. Global 3-Aminobenzylamine Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 18. Global 3-Aminobenzylamine Sales Market Share by Region (2020-2031)
 Figure 19. Global 3-Aminobenzylamine Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 20. Global 3-Aminobenzylamine Production Trend by Region (2020-2031) (Tons)
 Figure 21. Global 3-Aminobenzylamine Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. 3-Aminobenzylamine Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 24. 3-Aminobenzylamine Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 25. 3-Aminobenzylamine Production Growth Rate in China (2020-2031) & (Tons)
 Figure 26. 3-Aminobenzylamine Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 27. 3-Aminobenzylamine Production Growth Rate in India (2020-2031) & (Tons)
 Figure 28. Top 5 and Top 10 Manufacturers 3-Aminobenzylamine Sales Volume Market Share in 2024
 Figure 29. Global 3-Aminobenzylamine Revenue Market Share Ranking (2024)
 Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 31. Purity 99% Revenue Market Share by Manufacturer in 2024
 Figure 32. Purity 98% Revenue Market Share by Manufacturer in 2024
 Figure 33. Purity 97% Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 36. Global 3-Aminobenzylamine Sales Market Share by Type (2020-2031)
 Figure 37. Global 3-Aminobenzylamine Revenue Market Share by Type (2020-2031)
 Figure 38. Global 3-Aminobenzylamine Sales Market Share by Application (2020-2031)
 Figure 39. Global 3-Aminobenzylamine Revenue Market Share by Application (2020-2031)
 Figure 40. North America 3-Aminobenzylamine Sales YoY (2020-2031) & (Tons)
 Figure 41. North America 3-Aminobenzylamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. North America Top 5 Manufacturers 3-Aminobenzylamine Sales Revenue (US$ Million) in 2024
 Figure 43. North America 3-Aminobenzylamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 44. North America 3-Aminobenzylamine Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 45. North America 3-Aminobenzylamine Sales Volume (Tons) by Application (2020-2031)
 Figure 46. North America 3-Aminobenzylamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. US 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 49. Mexico 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe 3-Aminobenzylamine Sales YoY (2020-2031) & (Tons)
 Figure 51. Europe 3-Aminobenzylamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Europe Top 5 Manufacturers 3-Aminobenzylamine Sales Revenue (US$ Million) in 2024
 Figure 53. Europe 3-Aminobenzylamine Sales Volume (Tons) by Type (2020-2031)
 Figure 54. Europe 3-Aminobenzylamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Europe 3-Aminobenzylamine Sales Volume (Tons) by Application (2020-2031)
 Figure 56. Europe 3-Aminobenzylamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Germany 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 58. France 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 59. U.K. 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 60. Italy 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 61. Russia 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific 3-Aminobenzylamine Sales YoY (2020-2031) & (Tons)
 Figure 63. Asia-Pacific 3-Aminobenzylamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Asia-Pacific Top 8 Manufacturers 3-Aminobenzylamine Sales Revenue (US$ Million) in 2024
 Figure 65. Asia-Pacific 3-Aminobenzylamine Sales Volume (Tons) by Type (2020- 2031)
 Figure 66. Asia-Pacific 3-Aminobenzylamine Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 67. Asia-Pacific 3-Aminobenzylamine Sales Volume (Tons) by Application (2020-2031)
 Figure 68. Asia-Pacific 3-Aminobenzylamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Indonesia 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 70. Japan 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 73. India 3-Aminobenzylamine Revenue (2020-2031) & (US$ Million)
 Figure 74. Central and South America 3-Aminobenzylamine Sales YoY (2020-2031) & (Tons)
 Figure 75. Central and South America 3-Aminobenzylamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Central and South America Top 5 Manufacturers 3-Aminobenzylamine Sales Revenue (US$ Million) in 2024
 Figure 77. Central and South America 3-Aminobenzylamine Sales Volume (Tons) by Type (2021-2031)
 Figure 78. Central and South America 3-Aminobenzylamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Central and South America 3-Aminobenzylamine Sales Volume (Tons) by Application (2020-2031)
 Figure 80. Central and South America 3-Aminobenzylamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. Brazil 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 82. Argentina 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 83. Middle East, and Africa 3-Aminobenzylamine Sales YoY (2020-2031) & (Tons)
 Figure 84. Middle East and Africa 3-Aminobenzylamine Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Middle East and Africa Top 5 Manufacturers 3-Aminobenzylamine Sales Revenue (US$ Million) in 2024
 Figure 86. Middle East and Africa 3-Aminobenzylamine Sales Volume (Tons) by Type (2021-2031)
 Figure 87. South America 3-Aminobenzylamine Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Middle East and Africa 3-Aminobenzylamine Sales Volume (Tons) by Application (2020-2031)
 Figure 89. Middle East and Africa 3-Aminobenzylamine Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. GCC Countries 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 91. Turkey 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 92. Egypt 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 93. South Africa 3-Aminobenzylamine Revenue (2020-2025) & (US$ Million)
 Figure 94. 3-Aminobenzylamine Industry Chain Mapping
 Figure 95. Regional 3-Aminobenzylamine Manufacturing Base Distribution (%)
 Figure 96. 3-Aminobenzylamine Production Process
 Figure 97. Regional 3-Aminobenzylamine Production Cost Structure
 Figure 98. Channels of Distribution (Direct Vs Distribution)
 Figure 99. Bottom-up and Top-down Approaches for This Report
 Figure 100. Data Triangulation
 Figure 101. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD